Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease

Transplantation Proceedings

Volumn 32, Issue 2, 2000, Pages 331-333

  Kato, T ^a   Tokoro, T ^a   Namii, Y ^a   Kobayashi, T ^a   Hayashi, S ^a   Yokoyama, I ^a   Morimoto, S ^c   Chan, M ^b   Giannetti, N ^b   Hunt, S A ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b STANFORD UNIVERSITY   (United States)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PRAVASTATIN; PREDNISONE; SIMVASTATIN; TACROLIMUS; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHOLESTEROL; CORONARY DISEASE; FATTY ACIDS, MONOUNSATURATED; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; INDOLES; LOVASTATIN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRAVASTATIN; PYRROLES; SIMVASTATIN; TRIGLYCERIDES;

EID: 0034052483     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00971-9     Document Type: Article

References (29)

1. Bieber C.P., Hunt S.A., et al. Transplant Proc. 8:1983;207.
2. Serris G.E., Moore K.A., et al. J Thorac Surg. 108:1994;240.
3. Sharples L.D., Kain N., et al. Transplantation. 52:1991;244.
4. Barbir M., Rose M., et al. Int J Cardiol. 33:1991;241.
5. Ballantyne C.M., Radovancevic B., et al. J Am Coll Cardiol. 19:1992;1315.
6. Lipid Research Clinics Program: JAMA 251:351, 1984.
7. Kuo P.C., Kirshenbaum J.M., et al. Am J Cardiol. 64:1989;631.
8. Meiser B.M., Wenke K., et al. Transplant Proc. 25:1993;2077.
9. Peters J.R., Kubo S.H., et al. Am J Cardiol. 71:1993;1485.
10. Carrier M., Pelletier G.B., et al. Ann Thorac Surg. 57:1994;353.
11. Wenke K., Meiser B., et al. Circulation. 96:1997;1398.
12. Summary of the second report of National Cholesterol Education Program (NCEP) JAMA 269:3015, 1993.
13. Cutts J.L., Bankhurst A.D. J Cell Physiol. 145:1990;244.
14. Valantine H.A., Schroeder J.S. Circulation. 96:1997;1370.
15. Kobashigawa J.A., Katznelson S., et al. N Engl J Med. 333:1995;621.
16. Kakkis J.L., Ke B., et al. J Surg Res. 69:1997;393.
17. Katznelson S. Transplant Proc. 31:(suppl 3B):1999;22S.
18. Katznelson S., Wang X.M., et al. J Heart Lung Transplant. 17:1998;335.
19. Reichart B., Meiser B.M., et al. Kidney Int. 52:(suppl):1995;S52.
20. Southworth M.R., Mauro V.F. Ann Pharmacother. 31:1997;489.
21. Valantine-von Kaeppler H.A. Transplant Proc. 31:1999;1288.
22. Ballantyne C.M., Bourge R.C., et al. Am J Cardiol. 78:1996;532.
23. Gao S.Z., Schroeder J.S., et al. Circulation. 80:1989;100.
24. Spes C.H., Klauss V., et al. J Heart Lung Transplant. 18:1999;391.
25. Liang D.H., Gao S.Z., et al. J Heart Lung Transplant. 15:1996;980.
26. Rickenbacher P.R., Pinto F.J., et al. Circulation. 92:1995;3445.
27. Gregory C.R. Transplant Proc. 30:1998;878.
28. Katznelson S., Wang X.M., et al. J Heart Lung Transplant. 17:1998;335.
29. Maggard M.A., Ke B., Wang T., et al. Transplantation. 65:1998;149.